Literature DB >> 10363647

Proteasome-dependent degradation of human CDC25B phosphatase.

C Cans1, B Ducommun, V Baldin.   

Abstract

The CDC25 dual specificity phosphatase is a universal cell cycle regulator. The evolutionary conservation of this enzyme from yeast to man bears witness to its major role in the control of cyclin-dependent kinases (CDK) activity that are central regulators of the cell cycle machinery. CDC25 phosphatase both dephosphorylates and activates CDKs. Three human CDC25s have been identified. CDC25A is involved in the control of G1/S, and CDC25C at G2/M throught the activation of CDK 1-cyclin B. The exact function of CDC25B however remains elusive. We have found that CDC25B is degraded by the proteasome pathway in vitro and in vivo. This degradation is dependent upon phosphorylation by the CDK1-cyclin A complex, but not by CDK1-cyclin B. Together with the observations of others made in yeast and mammals, our results suggest that CDC25B might act as a 'mitotic starter' triggering the activation of an auto-amplification loop before being degraded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363647     DOI: 10.1023/a:1006912105352

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.

Authors:  Y Zeng; K C Forbes; Z Wu; S Moreno; H Piwnica-Worms; T Enoch
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

3.  Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?

Authors:  V Baldin; C Cans; G Superti-Furga; B Ducommun
Journal:  Oncogene       Date:  1997-05-22       Impact factor: 9.867

4.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.

Authors:  K Sadhu; S I Reed; H Richardson; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation.

Authors:  V Baldin; C Cans; M Knibiehler; B Ducommun
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

6.  Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects.

Authors:  P A Garner-Hamrick; C Fisher
Journal:  Int J Cancer       Date:  1998-05-29       Impact factor: 7.396

7.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

8.  Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.

Authors:  T Izumi; J L Maller
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

9.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.

Authors:  I Hoffmann; G Draetta; E Karsenti
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  8 in total

1.  Cell cycle-dependent Cdc25C phosphatase determines cell survival by regulating apoptosis signal-regulating kinase 1.

Authors:  Y-C Cho; J E Park; B C Park; J-H Kim; D G Jeong; S G Park; S Cho
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

2.  Identification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown.

Authors:  E A Powers; D P Thompson; P A Garner-Hamrick; W He; A W Yem; C A Bannow; D J Staples; G A Waszak; C W Smith; M R Deibel; C Fisher
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

3.  Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Authors:  Ge Li; Hyeon U Park; Dong Liang; Richard Y Zhao
Journal:  Retrovirology       Date:  2010-07-07       Impact factor: 4.602

4.  Sequence-specific activation of TAK1-D by short double-stranded RNAs induces apoptosis in NCI-H460 cells.

Authors:  Reinhard Kodym; Elisabeth Kodym; Micheal D Story
Journal:  RNA       Date:  2008-01-29       Impact factor: 4.942

5.  Degradation of proliferating cell nuclear antigen by 26S proteasome in rice (Oryza sativa L.).

Authors:  Taichi Yamamoto; Seisuke Kimura; Yoko Mori; Masayoshi Oka; Toyotaka Ishibashi; Yuki Yanagawa; Takayuki Nara; Hiroki Nakagawa; Junji Hashimoto; Kengo Sakaguchi
Journal:  Planta       Date:  2003-11-14       Impact factor: 4.116

6.  A general framework for modeling growth and division of mammalian cells.

Authors:  John H Gauthier; Phillip I Pohl
Journal:  BMC Syst Biol       Date:  2011-01-06

7.  Biochemical characterization of Cdk2-Speedy/Ringo A2.

Authors:  Aiyang Cheng; Shannon Gerry; Philipp Kaldis; Mark J Solomon
Journal:  BMC Biochem       Date:  2005-09-28       Impact factor: 4.059

8.  Kizuna is a novel mitotic substrate for CDC25B phosphatase.

Authors:  Yann Thomas; Marion Peter; Francisca Mechali; Jean-Marie Blanchard; Olivier Coux; Véronique Baldin
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.